Skip to main content
Fig. 9 | Respiratory Research

Fig. 9

From: ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways

Fig. 9

Effects of ZDHXB-101 on the activation of the Erk1/2, JNK MAPK and STAT3 pathways. The mouse lung tissues from different treatment groups were harvested and the phosphorylation of Erk1/2 (a), JNK (b), p38 (c) and STAT3 (d) was measured by Western blot. The data represent means ± S.D. (n = 8), *p < 0.05, **p < 0.01 and ***p < 0.001 vs. the control group. #p < 0.05 and ###p < 0.001 vs. the model group

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us